Click here to return to the Reference Table

Category: Musculoskeletal sarcomas
Cancer type: Osteosarcoma
Descriptor: Animal models

Reference Number: 145
Ferracini, R. et al. MET oncogene aberrant expression in canine osteosarcoma. J Orthop Res 18, 253-6. (2000).
PubMed link      E-mail link

Reference Number: 821
Fieten H, Spee B, Ijzer J, Kik MJ, Penning LC, Kirpensteijn J. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Vet Pathol. 46, 869-77 (2009)
PubMed link      E-mail link

Reference Number: 822
De Maria R, Miretti S, Iussich S, Olivero M, Morello E, Bertotti A, Christensen JG, Biolatti B, Levine RA, Buracco P, Di Renzo MF.
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma. J Pathol. 218, 399-408 (2009)

PubMed link      E-mail link

Reference Number: 990
Tsubaki M, Yamazoe Y, Yanae M, Satou T, Itoh T, Kaneko J, Kidera Y, Moriyama K, Nishida S. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-ß as angiogenic factors in mouse osteosarcoma. Cytokine. 54, 100-7 (2011)
PubMed link      E-mail link